Qiagen N.V. (QGEN)

業務介紹

QIAGEN N.V. 是一家在全球范圍內提供將生物材料轉化為分子洞察的樣本至洞察解決方案的公司。該公司提供原始樣本技術消耗品，如用於原始樣本材料的核酸穩定和純化試劑盒，用於基因分型、基因表達、病毒和細菌分析的手動和自動化處理，以及矽膜和磁珠技術；次級樣本技術消耗品，包括用於從次級樣本材料純化核酸的試劑盒和組件；以及核酸純化儀器和配件。它還提供結核病測試的干擾素-γ釋放試驗，以及用於移植後測試和病毒載量監測的試劑盒；用於產前檢測和性傳播疾病和人類乳頭瘤病毒的檢測試劑盒，以及用於基因組變異（如突變、插入、刪除和融合）分析的試劑盒；以及樣本至洞察儀器，包括一步分子分析難以診斷的綜合症的儀器和集成PCR測試。此外，它還提供定量PCR、逆轉錄和組合試劑盒等PCR消耗品，用於基因表達、基因分型和基因調控儀器和技術的分析；人類身份證和法醫學檢測試劑盒，包括用於人類身份證的STR檢測和食品污染的檢測試劑盒；PCR儀器包括數字PCR解決方案；以及開發和配置的OEM消耗品。此外，該公司還提供預定義和定制的下一代测序基因面板、文庫制備試劑盒和組件以及全基因組擴增；QIAGEN消耗品和儀器，以及生物信息學解決方案；以及定制實驗室和基因組服務。它為分子診斷、學術界、制藥和應用測試客戶提供服務。該公司與Sysmex Corporation和OncXerna Therapeutics簽訂了戰略聯盟協議，並與Mirati簽訂了協議。該公司成立於1986年，總部位於荷蘭的芬洛。

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

公司網址

https://www.qiagen.com